Schedule 13D ownership disclosure

Clementia Pharmaceuticals Inc.

Security class unavailable · CUSIP: 185575107

Event date: 2018-10-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
28.1600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000947871-18-000872
Form type
SC 13D/A
Filer
Clementia Pharmaceuticals Inc.
CIK
CIK 1647320
Filed
Nov 05, 2018
Reporting period
Oct 31, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub